Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Histone deacetylases, transcriptional control, and cancer.

Cress WD, Seto E.

J Cell Physiol. 2000 Jul;184(1):1-16. Review.

PMID:
10825229
2.

Chromatin remodeling and transcriptional regulation.

Luo RX, Dean DC.

J Natl Cancer Inst. 1999 Aug 4;91(15):1288-94. Review.

PMID:
10433617
3.

Control of histone modifications.

Davie JR, Spencer VA.

J Cell Biochem. 1999;Suppl 32-33:141-8. Review.

PMID:
10629113
4.

Epigenetic control of ovarian function: the emerging role of histone modifications.

LaVoie HA.

Mol Cell Endocrinol. 2005 Nov 24;243(1-2):12-8. Epub 2005 Oct 10. Review.

PMID:
16219412
5.
6.

Covalent modifications of histones: expression from chromatin templates.

Davie JR.

Curr Opin Genet Dev. 1998 Apr;8(2):173-8. Review.

PMID:
9610407
7.

Chromatin remodeling and cancer.

Davis PK, Brackmann RK.

Cancer Biol Ther. 2003 Jan-Feb;2(1):22-9. Review.

PMID:
12673113
8.

Class II histone deacetylases: structure, function, and regulation.

Bertos NR, Wang AH, Yang XJ.

Biochem Cell Biol. 2001;79(3):243-52. Review.

PMID:
11467738
9.

Histone acetylation in gene regulation.

Verdone L, Agricola E, Caserta M, Di Mauro E.

Brief Funct Genomic Proteomic. 2006 Sep;5(3):209-21. Epub 2006 Jul 28. Review.

PMID:
16877467
10.

Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs.

Hassig CA, Schreiber SL.

Curr Opin Chem Biol. 1997 Oct;1(3):300-8. Review.

PMID:
9667866
12.

Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation.

Lehrmann H, Pritchard LL, Harel-Bellan A.

Adv Cancer Res. 2002;86:41-65. Review.

PMID:
12374280
13.

Histone acetylation modifiers in the pathogenesis of malignant disease.

Mahlknecht U, Hoelzer D.

Mol Med. 2000 Aug;6(8):623-44. Review.

14.

Histone deacetylases and cancer.

Glozak MA, Seto E.

Oncogene. 2007 Aug 13;26(37):5420-32. Review.

PMID:
17694083
15.

Histone deacetylase. A key enzyme for the binding of regulatory proteins to chromatin.

López-Rodas G, Brosch G, Georgieva EI, Sendra R, Franco L, Loidl P.

FEBS Lett. 1993 Feb 15;317(3):175-80. Review.

16.

Regulation and regulatory parameters of histone modifications.

Davie JR, Chadee DN.

J Cell Biochem Suppl. 1998;30-31:203-13. Review.

PMID:
9893272
17.

Histone deacetylases (HDACs): characterization of the classical HDAC family.

de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB.

Biochem J. 2003 Mar 15;370(Pt 3):737-49. Review.

18.

HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.

Gallinari P, Di Marco S, Jones P, Pallaoro M, Steinkühler C.

Cell Res. 2007 Mar;17(3):195-211. Review.

19.

Histone acetylation and the cell-cycle in cancer.

Wang C, Fu M, Mani S, Wadler S, Senderowicz AM, Pestell RG.

Front Biosci. 2001 Apr 1;6:D610-29. Review.

PMID:
11282573
20.

Histone H2A ubiquitination in transcriptional regulation and DNA damage repair.

Zhou W, Wang X, Rosenfeld MG.

Int J Biochem Cell Biol. 2009 Jan;41(1):12-5. doi: 10.1016/j.biocel.2008.09.016. Epub 2008 Sep 26. Review.

PMID:
18929679

Supplemental Content

Support Center